Evidence map›Paper›PMID 34908920›Full record

ArticleFood & nutrition research2021

The mechanism and active compounds of semen

Yuehua Wang, Wenwen Gu, Fuguang Kui, Fan Gao, Yuji Niu, Wenwen Li, Yaru Zhang, Zhenzhen Guo, Gangjun Du

Open access · goldAbstract read
In one paragraph

Article in Food & nutrition research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Frontiers in pharmacology · 2024
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yuehua WangInstitute of Pharmacy, Pharmaceutical College of Henan University, Jinming District, Kaifeng, Henan Province, China.
Wenwen GuInstitute of Pharmacy, Pharmaceutical College of Henan University, Jinming District, Kaifeng, Henan Province, China.
Fuguang KuiInstitute of Pharmacy, Pharmaceutical College of Henan University, Jinming District, Kaifeng, Henan Province, China.
Fan GaoInstitute of Pharmacy, Pharmaceutical College of Henan University, Jinming District, Kaifeng, Henan Province, China.
Yuji NiuInstitute of Pharmacy, Pharmaceutical College of Henan University, Jinming District, Kaifeng, Henan Province, China.
Wenwen LiInstitute of Pharmacy, Pharmaceutical College of Henan University, Jinming District, Kaifeng, Henan Province, China.
Yaru ZhangInstitute of Pharmacy, Pharmaceutical College of Henan University, Jinming District, Kaifeng, Henan Province, China.
Zhenzhen GuoInstitute of Pharmacy, Pharmaceutical College of Henan University, Jinming District, Kaifeng, Henan Province, China.
Gangjun DuInstitute of Pharmacy, Pharmaceutical College of Henan University, Jinming District, Kaifeng, Henan Province, China.
Henan University · CNZhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) outbreak is progressing rapidly, and poses significant threats to public health. A number of clinical practice results showed that traditional Chinese medicine (TCM) plays a significant role for COVID-19 treatment.

objectiveTo explore the active components and molecular mechanism of semen

methodsThe active components and potential targets of semen

resultsThe network analysis revealed that nine key, active components regulated eight targets (Proto-oncogene tyrosine-protein kinase SRC (SRC), interleukin 6 (IL6), mitogen-activated protein kinase 1 (MAPK1), mitogen-activated protein kinase 3 (MAPK3), vascular endothelial growth factor A (VEGFA), epidermal growth factor receptor (EGFR), HRAS proto-oncogene (HRAS), caspase-3 (CASP3)). Gene ontology and KEGG enrichment analysis suggested that semen

conclusionAmygdalin is a candidate compound for COVID-19 treatment by regulating IL6, SRC, MAPK1 EGFR and VEGFA to involve in PI3K-Akt signalling pathway, VEGF signalling pathway and MAPK signalling pathway. Meanwhile, amygdalin has a strong affinity for SARS-CoV-2 3CLpro and SARS-CoV-2 ACE2 and therefore prevents the virus transcription and dissemination.

Indexed as

COVID-19molecular dockingnetwork pharmacologysemen armeniacae amarumtarget prediction

Identifiers

PMID34908920
PMCPMC8634376
OpenAlexW3127762319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.